First Trust NYSE Arca Biotechnology Index Fund
93 hedge funds and large institutions have $794M invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.04% more ownership
Funds ownership: 54.51% → 55.55% (+1%)
12% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $2.42M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
93
Holding in Top 10
2
Calls
$2.12M
Puts
$2.42M
Top Buyers
| 1 | +$67.3M | |
| 2 | +$48.7M | |
| 3 | +$33.2M | |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$9M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$3.27M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$11.4M | |
| 3 | -$6.11M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$4.97M |
| 5 |
VF
Virtu Financial
New York
|
-$3.99M |